United Therapeutics reported $894.8M in Cash and Equivalent for its fourth fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Cash And Equivalent Change
Bayer BAYN:GR € 4564M 248M
IONIS PHARMACEUT IONS:US $ 2115M 1482.05M
Lexicon Pharmaceuticals LXRX:US $ 59.52M 27.22M
Omeros OMER:US $ 8.96M 91.84M
Sangamo Biosciences SGMO:US $ 120.26M 58.62M
Teva Pharmaceutical TEVA:IT 2.16B 120M